Klaria Pharma Holding AB (KLAR) - Total Liabilities

Latest as of March 2026: Skr50.62 Million SEK ≈ $5.45 Million USD

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has total liabilities worth Skr50.62 Million SEK (≈ $5.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Klaria Pharma Holding AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Klaria Pharma Holding AB's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Klaria Pharma Holding AB's working capital to evaluate short-term liquidity relative to the company's equity base.

Klaria Pharma Holding AB Competitors by Total Liabilities

The table below lists competitors of Klaria Pharma Holding AB ranked by their total liabilities.

Company	Country	Total Liabilities
Wilton Resources Inc V:WIL	Canada	CA$668.49K
Celulosa Argentina SA BA:CELU	Argentina	AR$343.59 Billion
Grafton Group plc LSE:GFTU	UK	GBX1.26 Billion
Everest Metals Corporation Ltd AU:EMC	Australia	AU$1.66 Million
Hua Yang Bhd KLSE:5062	Malaysia	RM374.52 Million
Orion Digital Corp. NASDAQ:ORIO	USA	$100.11 Million
Pantera Silver Corp V:PNTR	Canada	CA$150.53K
Thai Film Industries Public Company Limited BK:TFI	Thailand	฿814.65 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Klaria Pharma Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Klaria Pharma Holding AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.06	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Klaria Pharma Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Klaria Pharma Holding AB (2014–2025)

The table below shows the annual total liabilities of Klaria Pharma Holding AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr44.65 Million ≈ $4.80 Million	-17.26%
2024-12-31	Skr53.96 Million ≈ $5.81 Million	+69.62%
2023-12-31	Skr31.81 Million ≈ $3.42 Million	-28.01%
2022-12-31	Skr44.19 Million ≈ $4.76 Million	-9.62%
2021-12-31	Skr48.89 Million ≈ $5.26 Million	+114.33%
2020-12-31	Skr22.81 Million ≈ $2.45 Million	+16.29%
2019-12-31	Skr19.62 Million ≈ $2.11 Million	+69.77%
2018-12-31	Skr11.55 Million ≈ $1.24 Million	+391.91%
2017-12-31	Skr2.35 Million ≈ $252.79K	+17.80%
2016-12-31	Skr1.99 Million ≈ $214.59K	-13.04%
2015-12-31	Skr2.29 Million ≈ $246.76K	+356.14%
2014-12-31	Skr502.69K ≈ $54.10K	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$20.99 Million

Skr195.06 Million SEK

Market Cap Rank

#24979 Global

#502 in Sweden

Share Price

Skr0.79

Change (1 day)

+0.63%

52-Week Range

Skr0.40 - Skr1.22

All Time High

Skr17.00